However, as provided in our study, Furiati et al. (2019) did not observe differences in the production of IFN-γ and IL-17 when comparing the CGs, patients with untreated psoriasis, and patients with psoriasis being treated with synthetic or biological DMARDs [51]. This evidence concerns the gene IL17A and psoriasis.